Vertex Introduces Vertex Sōl™, a Connected, AI-Powered Tax and Compliance Experience
Starting with the tax decision, Vertex Sōl connects the work, evidence, and AI that tax professionals control Starting with the tax decision, Vertex Sōl connects the work, evidence, and AI that tax professionals control
Covered in this story
Analyst targets on Vertex Pharmaceuticals
- UBS: $528 → $615 by Sep 2027 · Buy via Investing.com
- H.C. Wainwright: $515 → $641 by Sep 2027 · Buy via Investing.com
- BMO Capital Markets: $515 → $600 by Sep 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $VRTX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Vertex Pharmaceuticals →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.